You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Fidelis Insurance (FIHL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Read MoreHide Full Article
Fidelis Insurance Holdings (FIHL - Free Report) reported $686.6 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 27.7%. EPS of $0.92 for the same period compares to $0.77 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $691.89 million, representing a surprise of -0.76%. The company delivered an EPS surprise of +26.03%, with the consensus EPS estimate being $0.73.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Fidelis Insurance performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Combined Ratio: 87.4% versus the two-analyst average estimate of 90.7%.
Loss Ratio: 37.5% versus 43.3% estimated by two analysts on average.
Revenues- Net premiums earned: $634.50 million versus the two-analyst average estimate of $643.24 million.
Revenues- Net investment income: $52.10 million compared to the $48.66 million average estimate based on two analysts.
Shares of Fidelis Insurance have returned +1.3% over the past month versus the Zacks S&P 500 composite's +3.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
Fidelis Insurance (FIHL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Fidelis Insurance Holdings (FIHL - Free Report) reported $686.6 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 27.7%. EPS of $0.92 for the same period compares to $0.77 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $691.89 million, representing a surprise of -0.76%. The company delivered an EPS surprise of +26.03%, with the consensus EPS estimate being $0.73.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Fidelis Insurance performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Combined Ratio: 87.4% versus the two-analyst average estimate of 90.7%.
- Loss Ratio: 37.5% versus 43.3% estimated by two analysts on average.
- Revenues- Net premiums earned: $634.50 million versus the two-analyst average estimate of $643.24 million.
- Revenues- Net investment income: $52.10 million compared to the $48.66 million average estimate based on two analysts.
View all Key Company Metrics for Fidelis Insurance here>>>Shares of Fidelis Insurance have returned +1.3% over the past month versus the Zacks S&P 500 composite's +3.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.